Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction

Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction

Item
http://www.wikidata.org/entity/Q34231611
Andrographolide induces vascular smooth muscle cell apoptosis through a SHP-1-PP2A-p38MAPK-p53 cascade.Differential metabolic actions of specific statins: clinical and therapeutic considerationsA low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat heartsDysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury.Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats.Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes.Andrographolide, a Novel NF- κ B Inhibitor, Induces Vascular Smooth Muscle Cell Apoptosis via a Ceramide-p47phox-ROS Signaling Cascade.Atherosclerosis in chronic kidney disease: the role of macrophagesEffect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypLow-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.The effects of oleanolic acid on atherosclerosis in different animal models.Mitofusin2 decreases intracellular cholesterol of oxidized LDL-induced foam cells from rat vascular smooth muscle cells.Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
P2860

Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction

Item
http://www.wikidata.org/entity/Q34231611
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Combination therapy for treatm ...... on the lipid-RAAS interaction
@ast
Combination therapy for treatm ...... on the lipid-RAAS interaction
@en
Combination therapy for treatm ...... on the lipid-RAAS interaction
@nl
type
label
Combination therapy for treatm ...... on the lipid-RAAS interaction
@ast
Combination therapy for treatm ...... on the lipid-RAAS interaction
@en
Combination therapy for treatm ...... on the lipid-RAAS interaction
@nl
prefLabel
Combination therapy for treatm ...... on the lipid-RAAS interaction
@ast
Combination therapy for treatm ...... on the lipid-RAAS interaction
@en
Combination therapy for treatm ...... on the lipid-RAAS interaction
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Combination therapy for treatm ...... on the lipid-RAAS interaction
@en
P2093
P2860
P304
P31
P356
10.1016/J.ATHEROSCLEROSIS.2009.09.007
P433
P478
P577
P5875
P698
P921
P932